PREVIEW
As the importance of strict glycemic control has become increasingly recognized, the need for insulin preparations that more closely mimic physiologic insulin secretion is growing. Insulin analogues show great promise for helping diabetic patients achieve that control. In this article, the authors discuss the historical development of exogenous insulin preparations and the pharmacologic properties of insulin analogues, with emphasis on lispro, the first such agent to become commercially available.